These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 17763374

  • 1. 1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors.
    Penjisević J, Sukalović V, Andrić D, Kostić-Rajacić S, Soskić V, Roglić G.
    Arch Pharm (Weinheim); 2007 Sep; 340(9):456-65. PubMed ID: 17763374
    [Abstract] [Full Text] [Related]

  • 2. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ, Paluchowska MH, Duszyńska B, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E.
    Bioorg Med Chem; 2005 Mar 15; 13(6):2293-303. PubMed ID: 15727878
    [Abstract] [Full Text] [Related]

  • 3. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F, Perissutti E, Severino B, Santagada V, Cirillo D, Terracciano S, Massarelli P, Bruni G, Collavoli E, Renner C, Caliendo G.
    J Med Chem; 2005 Aug 25; 48(17):5495-503. PubMed ID: 16107148
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, binding properties and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands of D2 and 5-HT1A receptors.
    Andrić D, Roglić G, Sukalović V, Soskić V, Kostić-Rajacić S.
    Eur J Med Chem; 2008 Aug 25; 43(8):1696-705. PubMed ID: 18006194
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs.
    Sukalović V, Andrić D, Roglić G, Kostić-Rajacić S, Schrattenholz A, Soskić V.
    Eur J Med Chem; 2005 May 25; 40(5):481-93. PubMed ID: 15893022
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands.
    Chu W, Tu Z, McElveen E, Xu J, Taylor M, Luedtke RR, Mach RH.
    Bioorg Med Chem; 2005 Jan 03; 13(1):77-87. PubMed ID: 15582454
    [Abstract] [Full Text] [Related]

  • 7. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G, Butini S, Fattorusso C, Catalanotti B, Gemma S, Nacci V, Morelli E, Cagnotto A, Mereghetti I, Mennini T, Carli M, Minetti P, Di Cesare MA, Mastroianni D, Scafetta N, Galletti B, Stasi MA, Castorina M, Pacifici L, Vertechy M, Di Serio S, Ghirardi O, Tinti O, Carminati P.
    J Med Chem; 2004 Jan 01; 47(1):143-57. PubMed ID: 14695828
    [Abstract] [Full Text] [Related]

  • 8. New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation.
    Liégeois JF, Deville M, Dilly S, Lamy C, Mangin F, Résimont M, Tarazi FI.
    J Med Chem; 2012 Feb 23; 55(4):1572-82. PubMed ID: 22268448
    [Abstract] [Full Text] [Related]

  • 9. 'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity.
    Zhang J, Zhang H, Cai W, Yu L, Zhen X, Zhang A.
    Bioorg Med Chem; 2009 Jul 15; 17(14):4873-80. PubMed ID: 19559623
    [Abstract] [Full Text] [Related]

  • 10. Role of serotonin and dopamine receptor binding in antipsychotic efficacy.
    Richtand NM, Welge JA, Logue AD, Keck PE, Strakowski SM, McNamara RK.
    Prog Brain Res; 2008 Jul 15; 172():155-75. PubMed ID: 18772032
    [Abstract] [Full Text] [Related]

  • 11. Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands.
    Caliendo G, Fiorino F, Perissutti E, Severino B, Gessi S, Cattabriga E, Borea PA, Santagada V.
    Eur J Med Chem; 2001 Jul 15; 36(11-12):873-86. PubMed ID: 11755230
    [Abstract] [Full Text] [Related]

  • 12. Modeling of the D2 dopamine receptor arylpiperazine binding site for 1-[2-[5-(1H-benzimidazole-2-thione)]ethyl]-4-arylpiperazines.
    Sukalović V, Zlatović M, Andrić D, Roglić G, Kostić-Rajaccić S, Soskić V.
    Arch Pharm (Weinheim); 2004 Sep 15; 337(9):502-12. PubMed ID: 15362123
    [Abstract] [Full Text] [Related]

  • 13. Bivalent ligand approach on 4-[2-(3-methoxyphenyl)ethyl]-1-(2-methoxyphenyl)piperazine: synthesis and binding affinities for 5-HT(7) and 5-HT(1A) receptors.
    Leopoldo M, Lacivita E, Colabufo NA, Niso M, Berardi F, Perrone R.
    Bioorg Med Chem; 2007 Aug 01; 15(15):5316-21. PubMed ID: 17517509
    [Abstract] [Full Text] [Related]

  • 14. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
    Jurczyk S, Kołaczkowski M, Maryniak E, Zajdel P, Pawłowski M, Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E, Bojarski AJ, Charakchieva-Minol S, Duszyńska B, Nowak G, Maciag D.
    J Med Chem; 2004 May 06; 47(10):2659-66. PubMed ID: 15115407
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.
    Asproni B, Pau A, Bitti M, Melosu M, Cerri R, Dazzi L, Seu E, Maciocco E, Sanna E, Busonero F, Talani G, Pusceddu L, Altomare C, Trapani G, Biggio G.
    J Med Chem; 2002 Oct 10; 45(21):4655-68. PubMed ID: 12361392
    [Abstract] [Full Text] [Related]

  • 16. Structure-activity relationship studies on the 5-HT(1A) receptor affinity of 1-phenyl-4-[omega-(alpha- or beta-tetralinyl)alkyl]piperazines. 4.
    Perrone R, Berardi F, Colabufo NA, Leopoldo M, Tortorella V, Fornaretto MG, Caccia C, McArthur RA.
    J Med Chem; 1996 Dec 06; 39(25):4928-34. PubMed ID: 8960552
    [Abstract] [Full Text] [Related]

  • 17. Benzimidazole derivatives. Part 5: design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands.
    López-Rodríguez ML, Benhamú B, Morcillo MJ, Tejada I, Avila D, Marco I, Schiapparelli L, Frechilla D, Del Río J.
    Bioorg Med Chem; 2004 Oct 01; 12(19):5181-91. PubMed ID: 15351401
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties.
    López-Rodríguez ML, Morcillo MJ, Fernández E, Porras E, Orensanz L, Beneytez ME, Manzanares J, Fuentes JA.
    J Med Chem; 2001 Jan 18; 44(2):186-97. PubMed ID: 11170628
    [Abstract] [Full Text] [Related]

  • 19. Novel benzothiazolin-2-one and benzoxazin-3-one arylpiperazine derivatives with mixed 5HT1A/D2 affinity as potential atypical antipsychotics.
    Taverne T, Diouf O, Depreux P, Poupaert JH, Lesieur D, Guardiola-Lemaître B, Renard P, Rettori MC, Caignard DH, Pfeiffer B.
    J Med Chem; 1998 Jun 04; 41(12):2010-8. PubMed ID: 9622542
    [Abstract] [Full Text] [Related]

  • 20. A new class of arylpiperazine derivatives: the library synthesis on SynPhase lanterns and biological evaluation on serotonin 5-HT(1A) and 5-HT(2A) receptors.
    Zajdel P, Subra G, Bojarski AJ, Duszyńska B, Pawłowski M, Martinez J.
    J Comb Chem; 2004 Jun 04; 6(5):761-7. PubMed ID: 15360211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.